Jinxiu Lin

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 11

Top Topics

Carbon Nanotubes

Angiotensin Converting Enzyme

Hypertensive Patients

Top Venues

Journal of clinical hypertension (Greenwich, Conn.)

Oxidative medicine and cellular longevity

This page only lists publications with an associated author ORCID identifier.

Publications

Han Cai, Zhoufei Fang, Xiangshu Wu, Wei Zhou, Jinxiu Lin, Feng Peng, Jinzi Su
Efficacy and safety of 3D reconstruction and basket multi-electrode renal denervation (RDN) for refractory hypertensive patients with chronic kidney disease. Journal of clinical hypertension (Greenwich, Conn.) 26 (4) (2024)
Han Cai, Zhoufei Fang, Xiangshu Wu, Wei Zhou, Jinxiu Lin, Feng Peng, Jinzi Su
Efficacy and safety of 3D reconstruction and basket multi-electrode renal denervation (RDN) for refractory hypertensive patients with chronic kidney disease. Journal of clinical hypertension (Greenwich, Conn.) (2024)
Han Cai, Zhoufei Fang, Xiangshu Wu, Wei Zhou, Jinxiu Lin, Feng Peng, Jinzi Su
Efficacy and safety of 3D reconstruction and basket multi-electrode renal denervation (RDN) for refractory hypertensive patients with chronic kidney disease. Journal of clinical hypertension (Greenwich, Conn.) 26 (4) (2024)
Han Cai, Zhoufei Fang, Xiangshu Wu, Wei Zhou, Jinxiu Lin, Feng Peng, Jinzi Su
Efficacy and safety of 3D reconstruction and basket multi-electrode renal denervation (RDN) for refractory hypertensive patients with chronic kidney disease. Journal of clinical hypertension (Greenwich, Conn.) 26 (4) (2024)
Han Cai, Zhoufei Fang, Xiangshu Wu, Wei Zhou, Jinxiu Lin, Feng Peng, Jinzi Su
Efficacy and safety of 3D reconstruction and basket multi-electrode renal denervation (RDN) for refractory hypertensive patients with chronic kidney disease. Journal of clinical hypertension (Greenwich, Conn.) 26 (4) (2024)
Junxiong Lin, Qinghui Guo, Zhuoqiang Lu, Dajun Chai, Feng Peng, Jinxiu Lin
Cardiovascular outcomes of β-blocker-calcium channel blocker initial dual therapy vs. other initial dual therapies in Chinese patients with hypertension: A real-world retrospective study. Journal of clinical hypertension (Greenwich, Conn.) 25 (5) (2023)
Junxiong Lin, Qinghui Guo, Zhuoqiang Lu, Dajun Chai, Feng Peng, Jinxiu Lin
Cardiovascular outcomes of β-blocker-calcium channel blocker initial dual therapy vs. other initial dual therapies in Chinese patients with hypertension: A real-world retrospective study. Journal of clinical hypertension (Greenwich, Conn.) 25 (5) (2023)
Junxiong Lin, Qinghui Guo, Zhuoqiang Lu, Dajun Chai, Feng Peng, Jinxiu Lin
Cardiovascular outcomes of β-blocker-calcium channel blocker initial dual therapy vs. other initial dual therapies in Chinese patients with hypertension: A real-world retrospective study. Journal of clinical hypertension (Greenwich, Conn.) (2023)
Junxiong Lin, Qinghui Guo, Zhuoqiang Lu, Dajun Chai, Feng Peng, Jinxiu Lin
Cardiovascular outcomes of β-blocker-calcium channel blocker initial dual therapy vs. other initial dual therapies in Chinese patients with hypertension: A real-world retrospective study. Journal of clinical hypertension (Greenwich, Conn.) 25 (5) (2023)
Yuansheng Wu, Meijin Zhang, Changsheng Xu, Dajun Chai, Feng Peng, Jinxiu Lin
Anti-Diabetic Atherosclerosis by Inhibiting High Glucose-Induced Vascular Smooth Muscle Cell Proliferation via Pin1/BRD4 Pathway. Oxidative medicine and cellular longevity 2020 (2020)
Meijin Zhang, Liming Lin, Changsheng Xu, Dajun Chai, Feng Peng, Jinxiu Lin
VDR Agonist Prevents Diabetic Endothelial Dysfunction through Inhibition of Prolyl Isomerase-1-Mediated Mitochondrial Oxidative Stress and Inflammation. Oxidative medicine and cellular longevity 2018 (2018)